Strive Pharmacy
- 503A
“EdgeRx works with a single network of compounding pharmacies: Strive Pharmacy, a US-licensed 503A pharmacy compounding prescription medications since 2018.”
Source: edgerx.org · Verified 2026-08-04
EdgeRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: knowing which pharmacy fills the vial — it names Strive Pharmacy
7.9
★★★★☆4/5
EdgeRx's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
$229/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at EdgeRx →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
Nothing can be bought yet. Prices and descriptions for both GLP-1 injections are up, but the protocols sit behind a waitlist and checkout has not opened for any of them. Strive Pharmacy, the sole 503A compounder named, makes the Tirzepatide and Semaglutide shots, each formulated with B12 and glycine to preserve muscle. Sexual health, hair, cognition and recovery form four further outcome categories at EdgeRx Health, LLC. Physician review is priced in, payment is cash, and Truemed carries HSA/FSA.
By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $229/moPrice shown up frontIncludes medication + consult46 statesPharmacy namedNo FDA letter on record
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to EdgeRx
★★★★☆4/5
Editorial score · methodology
$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →★★★☆☆3.3/5
Editorial score · methodology
$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →★★★★☆4.4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →EdgeRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $229/mo (Formulated with glycine + B12; compounded by Strive Pharmacy (503A). Protocol page states 'The Semaglutide protocol i...)
- What's included
- Medication · Consult · Shipping
- Availability
- 46 states
- FDA status
- No FDA warning letter on record
How EdgeRx scores
Six columns, each one computed from something EdgeRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
4.2/10$299/month is 12% above the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
10.0/10names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is high.
Accessibility10%
9.4/10Publishes coverage in 46 of 50 states.
Support10%
7.0/10The price covers medication, consult, shipping.
6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on EdgeRx
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
What signing up with EdgeRx involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1EdgeRx publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3A prescription is dispensed by Strive Pharmacy, which EdgeRx names publicly. Most sellers in this register do not.
- 4The monthly price is recorded as covering medication, consult, shipping.
Price shown before you start
- Cheapest standing monthly prices on record: semaglutide $229, tirzepatide $299. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for 46 of 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
EdgeRx support, as documented
- info@edgerx.org
GLP-1 medications EdgeRx offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Once-weekly subcutaneous injection, variable-dose vials, titrated by physician. Not currently available for purchase — waitlist only as of Aug 2026.Compounded
$229/mo
semaglutide
Formulated with glycine + B12; compounded by Strive Pharmacy (503A). Protocol page states 'The Semaglutide protocol is not currently available for purchase.'
Once-weekly subcutaneous injection, variable-dose vials, titrated by physician. Not currently available for purchase — waitlist only as of Aug 2026.Compounded
$299/mo
tirzepatide
Formulated with glycine + B12; compounded by Strive Pharmacy (503A). Protocol page states 'The Tirzepatide protocol is not currently available for purchase.'
Check the price yourself before you pay
Every figure here was read off EdgeRx's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
EdgeRx compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that EdgeRx routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
In its favor
- Semaglutide at $229 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- Coverage is published for 46 states
- Names Strive Pharmacy as the dispensing pharmacy, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What EdgeRx charges
EdgeRx lists $229/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide — $229/month
- Compounded tirzepatide — $299/month
The median standing price across the GLP-1 providers we track is about $169/month, so this is a premium, and a premium has to buy something. Check what is bundled before accepting it.
Breeze Meds dispenses semaglutide and tirzepatide from $199/month, which makes it the honest comparison to run before committing here.
What EdgeRx dispenses
EdgeRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product — the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
What we could verify
On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller such as CoreAge Rx will usually win that arithmetic.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you need access regardless of where you live
Our read
EdgeRx costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Direct Meds is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
EdgeRx's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Score: 7.9/10Best for: knowing which pharmacy fills the vial — it names Strive PharmacyFrom: $229/mo
Before you pay EdgeRx
Starting at $229/month. Check today's price, then book the free consultation.
Where EdgeRx is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this EdgeRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See EdgeRx's current pricing
Plans start at $229/month. The free consultation is where you learn whether you qualify, and what it costs today.
Not sold on EdgeRx?
Vetted alternatives